Harvard Bioscience stem cells in Russian tracheal transplants

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

(Nasdaq:HBIO), a life sciences tools company, says the first two successful stem cells laryngotracheal transplants have been completed in Russia, using the company’s specially designed bioreactor to grow the stem cells, which were taken from the patients’ bone marrow.

View the original article here: Harvard Bioscience stem cells in Russian tracheal transplants – The Business Journal

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend